Centre Technology Transfer CITTRU posted this:A NEW DRUG FOR THE PREVENTION AND TREATMENT OF FELINE HERPESVIRUS TYPE 1 (FHV-1) AND FELINE CALICIVIRUS (FCV) INFECTIONSThe subject of the proposed offer is a new innovation of the Jagiellonian University - a new potential drug - poly(sodium 4-styrenesulfonates), (PSSNa), which can be used for treatment of FHV-1 and FCV infections.
Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
Universitat Politècnica de Catalunya - UPC posted this:New device for laboratory animal telemetryA new implantable telemetry system for monitoring laboratory animals has been patented and developed. The device allows long term studies without any restriction on the positioning of the animal inside the cage. Partners to further develop the device and/or to establish commercial agreements along with technical cooperation are sought.
Radoslaw Rudz posted this:
Licensing Manager at Centre Technology Transfer CITTRU
Yissum - Research Development Company of the Hebrew University posted this:Mycobacterium marinum bacteria-based vaccine for fishMutant Mycobacterium marinum bacteria as a vaccine against Mycobacteriosis in fish Project ID : 24-2018-4681
Yissum - Research Development Company of the Hebrew University posted this:Non-Invasive Method for Identifying Gender and Fertility of Eggs Before HatchingCluster11 A system that can sort avian eggs by detecting pre-incubation fertility and pre-hatching sexing in a non-invasive procedure Project ID : 8-2009-2198
Universidad de Alcalá-OTRI posted this:Salts of pyridazino[2,3-a]pyrrolo[2,1-c]quinoxaline for the treatment of leishmania infections and diseases that involve the protein tyrosine phosphatise 1B (metabolic syndrome, diabetes and obesity)Research groups from the Department of Organic Chemistry and Inorganic Chemistry and the Department of Systems Biology of the University of Alcalá have developed pyridazino[2,3-a]pirrolo[2,1-c]-quinoxalinium salts as therapeutic agents in the treatment of leishmaniasis, metabolic syndrome, diabetes and obesity. The compounds exhibit high activity and selectivity for the Leishmania parasite, and they provide a new therapeutic tool for the treatment of type 2 diabetes. The group seeks pharmaceutical companies to reach licensing agreements or collaboration and commercial agreements with technical assistance.
DIT Hothouse posted this:BovAlert: Priority Animal Health TestingBovAlert is an electrochemical diagnostic device which tests the milk of animal herds for liver fluke, providing quick and easy information regarding disease status. The technology consists of a handheld electronic reader and an assay card for on-site field testing and validation.
Universidad de Alicante posted this:Innovative and efficient antifungal composition for pharmacological (human &veterinary treatment), phytosanitary and cleaning (detergents) applicationsThis technology aims to help controlling resistant strains of important filamentous fungi and yeast fungi (e.g. Candida spp.) originated after prolonged treatment with currently used antifungals. The present invention provides for these purposes: a) The use of novel antifungals (COS and chitosan). b) The combined use (synergical) with existing antifungals (e.g. fluconazole) to reduce their doses. c) The use of COS and chitosan (alone or in combination with existing synergical antifungals) with an inhibitor of ARL1 gene to increase the sensitivity of fungi (including yeast) or their chitosan oligosaccharides (COS). Several experiments carried out have shown the significant synergistic effect of the combination object of the present invention (chitosan or COS, and an inhibitor of ARL1 gene or a currently used antifungal such as fluconazole) in inhibiting growth of filamentous fungi and yeast. Chitosan and COS are non-toxic for mammals, and therefore, they have a particular interest to use them as antifungal agents in some applications.
Alphanosos posted this:Effiskin(r), a veterinary hygiene product adapted to dogs with pyoderma prone skinsWe are looking for distributors and/or licensees for Effiskin(r). This hygiene product is a lotion formulated around our patent pending alternative to antibiotics and chlorhexidine, a WECMEP (Water Extracts of Complex Mixes of Edible Plants) with a great safety profile. Successful animal model results and user testimony are available. Available as bulk formulation or finished product (spray), also for rebranding.
RAMOT at Tel Aviv University Ltd. posted this:Brain Injury Animal ModelsCognitive and behavioral measurements in mice, suitable for drug evaluation and medical device development in two animal models for brain injury in mice (minimal traumatic brain injury and blast-brain injury). Project ID : 12-2011-200
RAMOT at Tel Aviv University Ltd. posted this:Behavioral Animal ModelsBehavioral test services including pain, cognition, memory and motility in schizophrenia, depression and anxiety, and Carageenan-induced inflammation and pain. Ex vivo brain tissue services include brain tissue dissection and analysis, and protein analysis. Project ID : 12-2011-201
RAMOT at Tel Aviv University Ltd. posted this:Nanomedicine and RNAA multidisciplinary approach to research, including, to name a few, immunology, cell and molecular biology, protein engineering, genetics. Services include PK and bio-distribution of drugs in mice models and in vivo validation of new drug targets using RNA interference. Project ID : 12-2011-207
RAMOT at Tel Aviv University Ltd. posted this:Ophthalmic TestingConsultation and lab services are offered, with a focus on eye-related medical innovations from concept through to clinical trials. Project ID : 12-2011-212